Announcement PDF Appendix 3Y Rule 3.19A.2 Change of Director’s Interest Notice Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public. Introduced 30/09/01 Amended 01/01/11 Name of entity Emyria Limited ACN 625 085 734 We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act. Name of Director Dr Michael Winlo Date of last notice 11 February 2020 Part 1 - Change of director’s relevant interests in securities In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part. Direct or indirect interest Indirect Nature of indirect interest (including registered holder) Michael Gordon Winlo <The Winlo A/C> (Michael Winlo is trustee and a beneficiary of this trust) Date of change 13 November 2020 No. of securities held prior to change Michael Gordon Winlo <The Winlo A/C> 3,500,000 Unlisted Options exercisable at $0.45 on or before 13 June 2023 Note: Provide details of the circumstances giving rise to the relevant interest. (note registered holder correction from previous notice) Class Unlisted Options Number acquired 4,000,000 Number disposed - Value/Consideration Nil Note: If consideration is non-cash, provide details and estimated valuation No. of securities held after change Michael Gordon Winlo <The Winlo A/C> 3,500,000 Unlisted Options exercisable at $0.45 on or before 13 June 2023 4,000,000 Unlisted Options exercisable at $0.114 on or before 13 November 2024 Nature of change Issue of Unlisted Options following shareholder approval at AGM Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back Part 2 – Change of director’s interests in contracts – N/A Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part. Detail of contract N/A Nature of interest Name of registered holder (if issued securities) N/A N/A Date of change N/A No. and class of securities to which N/A interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed Interest acquired N/A Interest disposed N/A Value/Consideration N/A Interest after change N/A Note: If consideration is non-cash, provide details and an estimated valuation Part 3 – +Closed period Were the interests in the securities or contracts detailed above No traded during a +closed period where prior written clearance was required? If so, was prior written clearance provided to allow the trade to N/A proceed during this period? If prior written clearance was provided, on what date was this N/A provided? Appendix 3Y Change of Director’s Interest Notice Rule 3.19A.s Appendix 3Y Change of Director’s Interest Notice Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and made be made public. Introduced 30/09/2001 Name of entity: Emerald Clinics Limited ABN: 625 085 734 We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act. Name of Director: Alistair Vickery Date of last notice: 23 October 2020 Part 1 - Change of director’s relevant interests in securities Note: In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust. In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part. Direct or indirect interest Direct and Indirect Nature of indirect interest (including registered holder) Netwealth Investments Limited <Super Services A/C> Note: Provide details of the circumstances giving rise to the relevant interest. Dr Vickery is a member of a managed superannuation fund Cherylyn Vickery <Vickery Family Trust> Dr Vickery is a beneficiary of this trust> Date of change 13 November 2020 No. of securities held prior to change Alistair Vickery Netwealth Investments Limited <Super Services A/C> 128,000 Ordinary Shares Alistair Vickery 2,000,000 Unlisted Options exercisable at $0.45 on or before 13 June 2023 Class changed Unlisted Options Number acquired 2,000,000 Number disposed - Value/Consideration Nil Note: If consideration is non-cash, provide details and estimated valuation No. of securities held after change Netwealth Investments Limited <Super Services A/C> + See chapter 19 for defined terms Appendix 3Y pg. 1 Appendix 3Y Change of Director’s Interest Notice 128,000 Ordinary Shares Alistair Vickery 2,000,000 Unlisted Options exercisable at $0.45 on or before 13 June 2023 Cherylyn Vickery <Vickery Family Trust> 2,000,000 Unlisted Options exercisable at $0.114 on or before 13 November 2024 Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back Issue of Unlisted Options following shareholder approval at AGM Part 2 - Change of director’s interests in contracts Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part. Detail of contract N/A Nature of interest N/A Name of registered holder (if issued securities) N/A Date of change N/A No. and class of securities to which interest related prior to change N/A Interest acquired N/A Interest disposed N/A Value/Consideration N/A Interest after changes N/A Note: Details are only required for a contract in relation to which the interest has changed Note: if consideration is non-cash, provide details and an estimated valuation Part 3 – Closed Period Were the interests in the securities or contracts detailed above traded during a +closed period where prior written clearance was required? No If so, was prior written clearance provided to allow the trade to proceed during this period? N/A If prior written clearance was provided, on what date was this provided? N/A + See chapter 19 for defined terms Appendix 3Y pg. 2 Appendix 3Y Rule 3.19A.2 Change of Director’s Interest Notice Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public. Introduced 30/09/01 Amended 01/01/11 Name of entity Emyria Limited ACN 625 085 734 We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act. Name of Director Mr Matthew Callahan Date of last notice 11 February 2020 Part 1 - Change of director’s relevant interests in securities In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part. Direct or indirect interest Indirect Nature of indirect interest (including registered holder) Mercator Shipwrights Pty Ltd <Mercator Trust> (Mr Callahan is a Note: Provide details of the circumstances giving rise to the relevant interest. beneficiary of this Trust) Shenasaby Pty Ltd < Shenasaby Trust> (Mr Callahan is a beneficiary of this trust) Date of change 13 November 2020 No. of securities held prior to change Mercator Shipwrights Pty Ltd <Mercator Trust> 19,600,000 Ordinary Shares Class Unlisted Options Number acquired 1,500,000 Number disposed - Value/Consideration Nil No. of securities held after change Mercator Shipwrights Pty Ltd <Mercator Trust> 19,600,000 Ordinary Shares Note: If consideration is non-cash, provide details and estimated valuation Shenasaby Pty Ltd < Shenasaby Trust> 1,500,000 Unlisted options exercisable at $0.114 on or before 13 November 2024 Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back Issue of Unlisted Options following shareholder approval at AGM Part 2 – Change of director’s interests in contracts – N/A Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part. Detail of contract N/A Nature of interest Name of registered holder (if issued securities) N/A N/A Date of change N/A No. and class of securities to which N/A interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed Interest acquired N/A Interest disposed N/A Value/Consideration N/A Interest after change N/A Note: If consideration is non-cash, provide details and an estimated valuation Part 3 – +Closed period Were the interests in the securities or contracts detailed above No traded during a +closed period where prior written clearance was required? If so, was prior written clearance provided to allow the trade to N/A proceed during this period? If prior written clearance was provided, on what date was this N/A provided? Appendix 3Y Rule 3.19A.2 Change of Director’s Interest Notice Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public. Introduced 30/09/01 Amended 01/01/11 Name of entity Emyria Limited ACN 625 085 734 We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act. Name of Director Sir John Tooke Date of last notice 11 February 2020 Part 1 - Change of director’s relevant interests in securities In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part. Direct or indirect interest Indirect Nature of indirect interest (including registered holder) Academic Health Solutions Ltd (John Tooke is a director and shareholder of the company) Date of change 13 November 2020 No. of securities held prior to change Academic Health Solutions Ltd 500,000 Unlisted Options exercisable at $0.45 on or before 13 June 2023 Class Unlisted Options Number acquired 1,000,000 Number disposed - Value/Consideration Nil Note: Provide details of the circumstances giving rise to the relevant interest. Note: If consideration is non-cash, provide details and estimated valuation No. of securities held after change Academic Health Solutions Ltd 500,000 Unlisted Options exercisable at $0.45 on or before 13 June 2023 Sir John Edward Tooke 1,000,000 Unlisted Options exercisable at $0.114 on or before 13 November 2024 Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back Issue of Unlisted Options following shareholder approval at AGM Part 2 – Change of director’s interests in contracts – N/A Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part. Detail of contract N/A Nature of interest Name of registered holder (if issued securities) N/A N/A Date of change N/A No. and class of securities to which N/A interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed Interest acquired N/A Interest disposed N/A Value/Consideration N/A Interest after change N/A Note: If consideration is non-cash, provide details and an estimated valuation Part 3 – +Closed period Were the interests in the securities or contracts detailed above No traded during a +closed period where prior written clearance was required? If so, was prior written clearance provided to allow the trade to N/A proceed during this period? If prior written clearance was provided, on what date was this N/A provided?